Last Price
15.80
Today's Change
-0.15 (0.94%)
Day's Change
15.41 - 16.00
Trading Volume
49,741
Overview
Market Cap
659 Million
Shares Outstanding
41 Million
Avg Volume
36,945
Avg Price (50 Days)
12.89
Avg Price (200 Days)
12.14
PE Ratio
-9.75
EPS
-1.62
Earnings Announcement
08-Nov-2024
Previous Close
15.95
Open
15.58
Day's Range
15.41 - 16.0
Year Range
9.05 - 16.7
Trading Volume
49,741
Price Change Highlight
1 Day Change
-0.94%
5 Day Change
9.72%
1 Month Change
28.35%
3 Month Change
35.86%
6 Month Change
31.45%
Ytd Change
42.99%
1 Year Change
65.62%
3 Year Change
62.72%
5 Year Change
62.89%
10 Year Change
62.89%
Max Change
62.89%
News and Blogs
No result.
Company Profile
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Oculis Holding AG, a clinical-stage biopharmaceutical company, develops novel topical treatments for ophthalmic diseases for both back- and front-of-the-eye. The company's lead candidate is OCS-01, a topical dexamethasone formulation, which is in Phase 3 clinical trials for the treatment of diabetic macular edema; OCS-02, a topical biologic candidate that is in Phase 2b clinical trials for the treatment for keratoconjunctivitis sicca, or dry eye disease; and OCS-05, a novel neuroprotective agent for acute optic neuritis and other neuro-ophtha disorders, such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The company is based in Zug, Switzerland.
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Featured Posts
12
Apps
Top Articles
1
CEO Morning Brief
2
CEO Morning Brief
3
4
CEO Morning Brief
IMF Sees Growth Shift Towards BRICS and Away From G7 in New Outlook
5
#
Stock
Score
Daily Stocks
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
